Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Carmel Capital Partners LLC

Carmel Capital Partners LLC reduced its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 4.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,969 shares of the company’s stock after selling 188 shares during the period. Carmel Capital Partners LLC’s holdings in Cardinal Health were worth $469,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Cardinal Health by 35.2% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 32,520 shares of the company’s stock worth $3,871,000 after purchasing an additional 8,471 shares during the last quarter. CHURCHILL MANAGEMENT Corp raised its holdings in Cardinal Health by 1.5% in the 4th quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company’s stock valued at $28,435,000 after acquiring an additional 3,576 shares during the last quarter. Geode Capital Management LLC raised its holdings in Cardinal Health by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock valued at $633,298,000 after acquiring an additional 42,082 shares during the last quarter. Consolidated Planning Corp raised its holdings in Cardinal Health by 40.0% in the 4th quarter. Consolidated Planning Corp now owns 8,926 shares of the company’s stock valued at $1,056,000 after acquiring an additional 2,552 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Cardinal Health by 2.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after acquiring an additional 33,388 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Trading Up 0.9 %

Shares of Cardinal Health stock opened at $127.50 on Thursday. The company has a fifty day moving average price of $125.28 and a 200 day moving average price of $118.57. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The stock has a market cap of $30.80 billion, a price-to-earnings ratio of 23.79, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health’s payout ratio is currently 37.69%.

Analyst Ratings Changes

CAH has been the subject of several analyst reports. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a report on Tuesday, January 7th. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Mizuho began coverage on Cardinal Health in a report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective for the company. Wells Fargo & Company upped their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 4th. Finally, TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $139.36.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.